logo

Analyzing the Impact of Earnings Reports on China Pharma Holdings Inc Inc. (CPHI) Price Performance

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 24.86% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 32.32%. Over the past 30 days, the price of CPHI has fallen by 37.52%. And in the last five days, it has surged by 18.93%.

In terms of market performance, China Pharma Holdings Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $0.43 on 03/28/24, while the lowest value was $0.13 on 12/16/24.

52-week price history of CPHI Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. China Pharma Holdings Inc’s current trading price is -31.69% away from its 52-week high, while its distance from the 52-week low is 123.31%. The stock’s price range for this period has been between $0.13 and $0.43. The Healthcare sector company’s shares saw a trading volume of about 1.16 million for the day, which was lower than the average daily volume of 1.22 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

China Pharma Holdings Inc (CPHI) has experienced a quarterly rise of 61.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.59M and boasts a workforce of 239 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2163, with a change in price of +0.0336. Similarly, China Pharma Holdings Inc recorded 913,829 in trading volume during the last 100 days, posting a change of +13.09%.

CPHI’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CPHI stands at 0.61. Similarly, the long-term debt-to-equity ratio is also 0.22.

CPHI Stock Stochastic Average

As of today, the raw stochastic average of China Pharma Holdings Inc over the past 50 days is 79.93%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 79.68%. Additionally, the Stochastic %K and %D values for the company were 66.18% and 56.12%, respectively, over the past 20 days.

Most Popular